Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The provided name refers to several different gene products: - NADPH oxidase 4 (NOX4) - Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) - Myotubularin-related protein 3 (MTMR3) - Tribbles pseudokinase 2 (TRIB2). These are all separate proteins with distinct biological functions and disease associations. They do not form a single molecular entity or therapeutic target. The submitted "target" is an incorrect aggregation of several unrelated genes/proteins that should each be considered separately for structured data extraction. Each has its own canonical form with unique biological roles and disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple mRNAs including NADPH oxidase 4 NOX4 leucine rich repeat containing G protein-coupled receptor 5 LGR5 MTMR3 Trib2.